arrow
S

Sean Wei Xiang Ong

University of Melbourne and Peter Doherty Institute for Infection and Immunity
H指数:30
被引数:9,424

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCE

评估阴性菌血流感染平台试验的可行性:BALANCE先锋期结果

2025-12-040
OA
Comparing different methods for analyzing hierarchical composite endpoints: two illustrative case studies with post-hoc analyses of the BALANCE and CAMERA2 randomized clinical trials.

比较分析层级复合终点不同方法的比较:BALANCE和CAMERA2随机临床试验的事后分析两个说明性案例研究。

2025-11-280
OAAI
Clinician survey for the management of central venous catheter-related bloodstream infection: catheter retention versus replacement

临床医生调查:中心静脉导管相关血流感染的管理——导管保留与更换

2025-09-291
PRE
Modeling Antibody Kinetics Post-mRNA Booster Vaccination and Protection Durations Against SARS-CoV-2 Infection

mRNA加强疫苗接种后抗体动力学建模及对SARS-CoV-2感染的保护持续时间

2025-08-060
OA
Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post Hoc Analysis of Individual Participant Data From 2 Randomized Trials

Escrihuela-Vidal, F.; Ong, S.W.X.; Oriol, I.; Grillo, S.; Pujol, M.; Pallarès, N.; Tebé, C.; Liu, K.; Miró, J.M.; Tong, S.Y.C.; 等. 磷霉素作为辅助治疗金黄色葡萄球菌菌血症:一项基于2项随机试验的个人参与者数据的汇总事后分析。Clin. Infect. Dis. 2025, 80, ciaf387. [Google Scholar] [CrossRef]

2025-07-160
OAAI
Evaluating the clinical impact of targeting lower versus higher serum vancomycin trough: a retrospective study using a desirability of outcome ranking (DOOR) analysis

评估靶向较低与较高血清万古霉素谷浓度对临床影响的回顾性研究:一项采用结果期望性排序(DOOR)分析的研究

2025-05-150
PRE
Cefazolin vs. antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis

头孢唑林 vs. 抗金黄色葡萄球菌青霉素类治疗甲氧西林敏感金黄色葡萄球菌菌血症:一项系统评价和荟萃分析

2025-05-090
OAAI
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trial

识别血流感染中抗生素疗程的治疗效应异质性:BALANCE随机临床试验的探索性事后分析

2025-05-010
PRE
Defining the Critical Requisites for Accurate Simulation of SARS-CoV-2 Viral Dynamics: Patient Characteristics and Data Collection Protocol

定义准确模拟SARS-CoV-2病毒动力学所需的关键要素:患者特征与数据收集方案

2025-01-161
OAAI
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: fi nal results from the fi rst phase of the PRIBIVAC randomised clinical trial
2024-09-010
OAAI